Cargando…

Cardiovascular Risk Stratification and Statin Eligibility Based on the Brazilian vs. North American Guidelines on Blood Cholesterol Management

BACKGROUND: The best way to select individuals for lipid-lowering treatment in the population is controversial. OBJECTIVE: In healthy individuals in primary prevention: 1. to assess the relationship between cardiovascular risk categorized according to the V Brazilian Guideline on Dyslipidemia and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cesena, Fernando Henpin Yue, Laurinavicius, Antonio Gabriele, Valente, Viviane A., Conceição, Raquel D., Santos, Raul D., Bittencourt, Marcio S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489320/ https://www.ncbi.nlm.nih.gov/pubmed/28699974 http://dx.doi.org/10.5935/abc.20170088

Ejemplares similares

The Expected Cardiovascular Benefit of Plasma Cholesterol Lowering with or Without LDL-C Targets in Healthy Individuals at Higher Cardiovascular Risk
por: Cesena, Fernando Henpin Yue, et al.
Publicado: (2017)

Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis
por: Janovsky, Carolina Castro Porto Silva, et al.
Publicado: (2018)

Percepção Inadequada do Risco Cardiovascular e Baixo Conhecimento sobre Hipercolesterolemia Familiar em Indivíduos com Hipercolesterolemia Grave
por: Santos, Raul D., et al.
Publicado: (2021)

Risco Cardiovascular e Elegibilidade Para Estatina na Prevenção Primária: Comparação Entre a Diretriz Brasileira e a Diretriz da AHA/ACC
por: Cesena, Fernando H. Y., et al.
Publicado: (2020)

Razão Neutrófilo-Linfócito e Aterosclerose da Aorta Abdominal entre Indivíduos Assintomáticos
por: Marin, Bárbara Said, et al.
Publicado: (2022)

Job Stress and Cardiovascular Health: Is There a Connection?
por: Cesena, Fernando Henpin Yue
Publicado: (2019)

2251. Comparing Statin Prescribing Rates in Eligible HIV vs. Non-HIV-Infected Patients
por: Blackman, Alison, et al.
Publicado: (2018)

Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals
por: Mosepele, Mosepele, et al.
Publicado: (2018)

Cardiovascular Risk Stratification: From Phenotype to Genotype?
por: Bittencourt, Marcio Sommer
Publicado: (2018)

Statin Eligibility and Outpatient Care Prior to ST‐Segment Elevation Myocardial Infarction
por: Miedema, Michael D., et al.
Publicado: (2017)

Implications of the US Cholesterol Guidelines on Eligibility for Statin Therapy in the Community: Comparison of Observed and Predicted Risks in the Framingham Heart Study Offspring Cohort
por: Andersson, Charlotte, et al.
Publicado: (2015)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Association of subclinical inflammation, glycated hemoglobin and risk for obstructive sleep apnea syndrome
por: D’Aurea, Carolina Vicaria Rodrigues, et al.
Publicado: (2017)

Novel method versus the Friedewald method for estimating low-density lipoprotein cholesterol in determination of the eligibility for statin treatment for primary prevention in the United States
por: Shin, Doosup, et al.
Publicado: (2018)

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study
por: Moon, Byung Sub, et al.
Publicado: (2016)

Statins: Cholesterol guidelines and Indian perspective
por: Menon, Anil S., et al.
Publicado: (2015)

Cholesterol suppresses antimicrobial effect of statins
por: Haeri, Mohammad Reza, et al.
Publicado: (2015)

PB1993: MULTIPLE MYELOMA BRAZILIAN REGISTER- HOW ABOUT THE TRANSPLANT ELIGIBLE PATIENTS?
por: Crusoe, E., et al.
Publicado: (2022)

‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
por: Murphy, Michael J, et al.
Publicado: (2008)

Low eligibility for hepatitis B treatment in the Brazilian public health system
por: Scarponi, Cristiane Faria Oliveira, et al.
Publicado: (2022)

Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017)

Racial Differences in the Cholesterol-Lowering Effect of Statin
por: Naito, Ryo, et al.
Publicado: (2017)

Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data*
por: Fox, K M, et al.
Publicado: (2007)

A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening
por: Dennison, Rebecca A., et al.
Publicado: (2022)

Eligible-and-enrolled vs. eligible-but-not-enrolled patients with chronic ischaemic heart failure in randomized clinical trials of myocardial regeneration
por: Czyż, Łukasz, et al.
Publicado: (2022)

Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program
por: Faisal-Cury, Alexandre, et al.
Publicado: (2020)

Risk Stratification in Cost-Effectiveness Analyses of Cancer Screening: Intervention Eligibility, Strategy Choice, and Optimality
por: O’Mahony, James F.
Publicado: (2021)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial
por: Vassy, Jason L., et al.
Publicado: (2020)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
por: Grigore, Liliana, et al.
Publicado: (2008)

Impact of prescription size on statin adherence and cholesterol levels
por: Batal, Holly A, et al.
Publicado: (2007)

Atherosclerosis, cholesterol, nutrition, and statins – a critical review
por: Gebbers, Jan-Olaf
Publicado: (2007)

Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
por: Joo, Seung-Jae
Publicado: (2012)

Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins
por: Reid, Patrick C, et al.
Publicado: (2007)

RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2012)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Decreasing cholesterol levels in the community – lifestyle change with statin?
por: Savolainen, Jorma, et al.
Publicado: (2015)

Coronaviruses, cholesterol and statins: Involvement and application for Covid-19
por: Orlowski, Stéphane, et al.
Publicado: (2021)

Forecasting Cholesterol Management-End of the Statin Gold Rush?
por: Crownover, Brian K., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_oj24he9bahhl9j1i7o5u4j5206